HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US Cosmetics Reform Talks To Resume In 2021 After COVID Derailing, Anti-Regulation Trump

Executive Summary

Efforts to modernize US cosmetics regulations fell short in the 116th Congress as lawmakers swung their focus to COVID-19, but industry expects a resumption of discussions in the next term, even as pandemic relief and recovery remains top priority.

You may also be interested in...



PCPC Leadership On US Legislative Landscape, EU Microplastic Restriction, Other 2021 Concerns

The Personal Care Products Council’s government affairs heads, chief scientist and executive VP of global strategies discuss the trade association’s 2021 priorities and preoccupations.

NGOs To Assert COVID-Unsafe Cosmetic Ingredients In Next US Legislative Reform Push

The Campaign for Safe Cosmetics, powered by Breast Cancer Prevention Partners and the Environmental Working Group, intends to present the 117th Congress with links between cosmetic ingredients and increased COVID susceptibility as part of its push for tighter cosmetics industry oversight.

EWG Study Suggests More Than One In 10 Talc-Based Cosmetics Contain Asbestos

The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.

Related Content

Topics

UsernamePublicRestriction

Register

RS150721

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel